Useful on all types including Delta; Testimony of practitioners
A study in the United States has shown that the vaccine developed so far to prevent corona is the SARS COV, or Covid 19 virus.
Comparisons based on the national data set showed that the modern vaccine is more effective on the delta subtype of the corona than the Pfizer and Johnson & Johnson vaccines. Based on factual information, these vaccines reduced the chances of coronary heart disease being hospitalized. They did not have to be admitted to the emergency department. In the case of Delta, in particular, those who were vaccinated with Moderna were more effective than those who were vaccinated with Pfizer and Johnson & Johnson, said Shawn Granis, vice president of data and analytics at the Regenstein Institute.
Granis said vaccines need to be used to prevent serious illness and reduce stress on the health system. The Vision Network analyzed the corona infection of 32,000 people in nine states during the June, July and August Delta virus episodes. It found that those who were vaccinated were 5 to 7 times less likely to be hospitalized than those who were not vaccinated. The vaccine has been shown to be as effective in the Delta virus as it has been in previous cases.
The Mortality and Mortality Weekly Report states that mRNA vaccines have been shown to be more effective. The modern vaccine has been shown to be 95 percent effective in reducing hospital admissions in people 18 years of age and older, while the Pfizer vaccine has been shown to be 80 percent effective and the Johnson & Johnson vaccine 60 percent effective. Vaccines have been shown to be less effective for people aged 75 and over. The modern vaccine is effective at 92 percent, the Pfizer vaccine at 77 percent, and the Johnson & Johnson vaccine at 65 percent. Despite the differences in effectiveness, all of these vaccines provide protection against corona, Granis said.